| |
| |
|
| Insider
Information: |
Kassberg Thomas Richard |
| Relationship: |
|
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
252,823 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$10,148,315 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
252,823 |
|
|
| Total
Value |
$10,148,315 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
10
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
9
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -239.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
InterMune Inc |
ITMN |
Former SVP-Cor.Dev.Com... |
2007-12-28 |
0 |
2006-01-16 |
0 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
|
2024-03-11 |
252,823 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2021-03-01 |
4 |
S |
$138.17 |
$631,713 |
D/D |
(4,572) |
107,181 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2021-05-06 |
4 |
S |
$113.69 |
$41,269 |
D/D |
(363) |
106,818 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & Senior Vice President |
• – – |
2015-08-12 |
4 |
AS |
$109.70 |
$365,740 |
D/D |
(3,334) |
70,204 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & Senior Vice President |
• – – |
2015-07-08 |
4 |
AS |
$102.12 |
$340,468 |
D/D |
(3,334) |
73,538 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & Senior Vice President |
• – – |
2015-06-10 |
4 |
AS |
$88.19 |
$294,025 |
D/D |
(3,334) |
76,872 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2020-10-14 |
4 |
S |
$87.98 |
$23,051 |
D/D |
(262) |
101,478 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2021-10-14 |
4 |
S |
$81.14 |
$23,206 |
D/D |
(286) |
216,266 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2018-06-01 |
4 |
D |
$73.73 |
$25,511 |
D/D |
(346) |
83,114 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & Senior Vice President |
• – – |
2015-05-13 |
4 |
AS |
$72.04 |
$240,181 |
D/D |
(3,334) |
75,806 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2020-06-01 |
4 |
D |
$69.38 |
$24,144 |
D/D |
(348) |
101,740 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2019-03-01 |
4 |
D |
$67.55 |
$54,445 |
D/D |
(806) |
89,499 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2022-03-11 |
4 |
S |
$67.01 |
$688,930 |
D/D |
(10,281) |
227,559 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2022-03-01 |
4 |
S |
$66.62 |
$158,156 |
D/D |
(2,374) |
213,840 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2020-05-06 |
4 |
D |
$66.26 |
$16,432 |
D/D |
(248) |
101,675 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2019-03-05 |
4/A |
S |
$65.52 |
$54,513 |
D/D |
(832) |
89,474 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2018-05-21 |
4 |
D |
$64.79 |
$24,685 |
D/D |
(381) |
83,460 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2019-04-19 |
4 |
D |
$64.43 |
$15,979 |
D/D |
(248) |
89,226 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & Senior Vice President |
• – – |
2016-05-21 |
4 |
D |
$64.01 |
$26,500 |
D/D |
(414) |
69,790 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2019-05-21 |
4 |
D |
$59.50 |
$22,670 |
D/D |
(381) |
90,587 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2020-04-19 |
4 |
D |
$58.57 |
$14,525 |
D/D |
(248) |
101,923 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & Senior Vice President |
• – – |
2015-04-08 |
4 |
AS |
$58.02 |
$193,381 |
D/D |
(3,333) |
79,140 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2017-05-21 |
4 |
D |
$57.47 |
$23,793 |
D/D |
(414) |
76,604 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2017-06-01 |
4 |
D |
$56.61 |
$21,285 |
D/D |
(376) |
76,228 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & Senior Vice President |
• – – |
2015-03-11 |
4 |
AS |
$56.30 |
$187,648 |
D/D |
(3,333) |
82,473 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CBO & EVP |
• – – |
2020-03-01 |
4 |
D |
$56.08 |
$115,917 |
D/D |
(2,067) |
102,171 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
